When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
In the Blink of an Eye
Pain is a Four-Letter Word
Recipe for a Happy (and Healthy) Thanksgiving
Food as Medicine
Giving Kids a Shot
Breaking Up with Your Bad Habits
Facing Your Fears
What Are You Waiting For?
The Power of Nudges
Trust Me
Why Am I So Angry?
Preparing for the Next Pandemic
Feeling the Heat
Chasing a Cure
Presenting Hidden Brain: Unlocking Your Purpose
Presenting NPR's Life Kit: How To Deal With Burnout
Helping Grandma and Grandpa Get Back in the Groove
Olympians Go For Gold — Without Fans
Let’s Talk About Making Babies (Or Deciding Not To)
Tig Notaro on the Healing Power of Laughter
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Up First